​

Arcutis Biotherapeutics Ownership | Who Owns Arcutis Biotherapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Arcutis Biotherapeutics Ownership Summary

Arcutis Biotherapeutics is owned by 99.59% institutional investors, 1.93% insiders. Jennison associates is the largest institutional shareholder, holding 9.65% of ARQT shares. Polar Capital Biotech S Inc is the top mutual fund, with 4.17% of its assets in Arcutis Biotherapeutics shares.

ARQT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockArcutis Biotherapeutics99.59%1.93%-1.52%
SectorHealthcare Stocks 492.67%11.09%-403.76%
IndustryBiotech Stocks 295.31%11.22%-206.53%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Jennison associates12.25M9.65%$230.99M
Rubric capital management lp10.75M8.46%$202.63M
Suvretta capital management10.48M8.25%$197.51M
Frazier life sciences management9.87M7.78%$186.13M
Blackrock8.62M7.76%$80.19M
Blackrock funding, inc. /de8.57M6.75%$161.62M
Vanguard group7.15M5.63%$134.70M
Polar capital5.30M4.17%$99.88M
State street4.64M3.65%$87.49M
Gilder gagnon howe4.43M3.49%$83.49M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Pivotal bioventure partners investment advisor2.12M23.11%$39.97M
Frazier life sciences management9.87M5.58%$186.13M
Tejara capital520.50K5.12%$9.81M
Suvretta capital management10.48M5.06%$197.51M
Lion point capital, lp35.30K3.78%$665.40K
Ally bridge group (ny)233.22K2.68%$4.40M
Rubric capital management lp10.75M2.29%$202.63M
Myda advisors470.00K1.91%$8.86M
Stempoint capital lp411.89K1.56%$7.76M
Privium fund management b.v.305.97K1.04%$5.77M

Top Buyers

HolderShares% AssetsChange
Perpetual2.02M0.47%2.00M
Blackrock8.62M0.00%1.96M
Millennium management2.31M0.02%1.16M
Jennison associates12.25M0.13%1.14M
Voloridge investment management833.49K0.05%833.49K

Top Sellers

HolderShares% AssetsChange
Point72 asset management---1.49M
Paradigm biocapital advisors lp---1.47M
Perceptive advisors---1.36M
Braidwell lp---1.30M
Suvretta capital management10.48M5.06%-1.06M

New Positions

HolderShares% AssetsChangeValue
Fishman jay a ltd/mi565.65K0.91%565.65K$10.66M
Norges bank532.79K0.00%532.79K$7.42M
Ally bridge group (ny)233.22K2.68%233.22K$4.40M
Jacobs levy equity management175.91K0.01%175.91K$1.64M
Eversept partners, lp111.47K0.14%111.47K$2.10M

Sold Out

HolderChange
Twin peaks wealth advisors-2.00
Parallel advisors-14.00
Nelson, van denburg & campbell wealth management group-22.00
Stephens consulting-25.00
Corecap advisors-38.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025234-6.02%126,474,0751.16%991.01%120-6.25%66-20.48%
Mar 31, 202524613.36%124,963,282-3.01%990.92%12716.51%8122.73%
Dec 31, 20242149.74%120,033,596-6.58%960.90%1073.88%6629.41%
Sep 30, 20241941.57%128,485,4751.57%1030.98%104-3.70%51-7.27%
Jun 30, 202419113.02%126,499,0251.37%1020.81%108-0.92%5544.74%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Polar Capital Biotech S Inc5.00M4.17%-
Vanguard US Total Market Shares ETF3.59M3.03%492.10K
Vanguard Total Stock Mkt Idx Inv3.39M2.83%-71.75K
Jennison SMid Cap Core Equity3.17M2.66%83.01K
PGIM Jennison Small Company A3.17M2.64%9.07K
iShares Russell 2000 ETF2.58M2.15%-
Jennison Health Sciences Equity2.27M1.90%-
PGIM Jennison Health Sciences Z2.27M1.89%-
SPDR® S&P Biotech ETF1.88M1.57%4.20K
Franklin Biotechnology Discv A(acc)USD1.61M1.34%-77.76K

Recent Insider Transactions

DateNameRoleActivityValue
Nov 06, 2025Edwards Larry Todd See RemarksSell$732.93K
Nov 06, 2025Burnett Patrick See RemarksSell$417.14K
Nov 05, 2025Burnett Patrick See RemarksSell$91.64K
Nov 03, 2025Burnett Patrick See RemarksSell$64.43K
Nov 03, 2025Burnett Patrick See RemarksSell$381.00

Insider Transactions Trends

DateBuySell
2025 Q4-17
2025 Q3-15
2025 Q2910
2025 Q1-18
2024 Q4314

ARQT Ownership FAQ

Who Owns Arcutis Biotherapeutics?

Arcutis Biotherapeutics shareholders are primarily institutional investors at 99.59%, followed by 1.93% insiders and -1.52% retail investors. The average institutional ownership in Arcutis Biotherapeutics's industry, Biotech Stocks , is 295.31%, which Arcutis Biotherapeutics falls below.

Who owns the most shares of Arcutis Biotherapeutics?

Arcutis Biotherapeutics’s largest shareholders are Jennison associates (12.25M shares, 9.65%), Rubric capital management lp (10.75M shares, 8.46%), and Suvretta capital management (10.48M shares, 8.25%). Together, they hold 26.36% of Arcutis Biotherapeutics’s total shares outstanding.

Does Blackrock own Arcutis Biotherapeutics?

Yes, BlackRock owns 7.76% of Arcutis Biotherapeutics, totaling 8.62M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 80.19M$. In the last quarter, BlackRock increased its holdings by 1.96M shares, a 29.49% change.

Who is Arcutis Biotherapeutics’s biggest shareholder by percentage of total assets invested?

Pivotal bioventure partners investment advisor is Arcutis Biotherapeutics’s biggest shareholder by percentage of total assets invested, with 23.11% of its assets in 2.12M Arcutis Biotherapeutics shares, valued at 39.97M$.

Who is the top mutual fund holder of Arcutis Biotherapeutics shares?

Polar Capital Biotech S Inc is the top mutual fund holder of Arcutis Biotherapeutics shares, with 4.17% of its total shares outstanding invested in 5M Arcutis Biotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools